Department of Gastroenterology, Keiyukai Sapporo Hospital, Sapporo, Japan.
Gastrointest Endosc. 2010 Aug;72(2):255-64, 264.e1-2. doi: 10.1016/j.gie.2010.02.040. Epub 2010 Jun 11.
Endoscopic submucosal dissection (ESD) was originally developed in Japan for en bloc resection of gastric neoplasms.
To clarify whether the novel ESD procedure is feasible and gives results that justify the pursuit of integrated minimally invasive procedures aimed at curing early squamous cell carcinoma of the esophagus (SCCE).
Retrospective cohort study.
A single-institution trial by experienced endoscopists.
This study involved 300 consecutively enrolled patients with SCCE (Tumor, Nodes, Metastasis classification T1, N0) who underwent either EMR (n = 184) or ESD (n = 116) from March 1994 to July 2007.
The patients underwent endoscopic resection and then were followed by periodic endoscopy for 8 to 174 months (mean 65 months).
Resectability, cure rates, complications, disease-free survival of the two groups, and risk factors for local recurrence were explored.
En bloc resection and the local recurrence rate were significantly better in the ESD group (P = .0009 and .065, respectively). The frequency of perforation was not significantly different between the two groups (P = .68). Four independent risk factors for local recurrence were identified by the Cox regression model: EMR, deep cancer invasion, upper esophagus location, and family history of esophageal cancer. Radical cure is mostly obtained by successful endoscopic retreatment of local recurrence after previous endoscopic resection. Disease-free survival was significantly better with ESD.
The study's retrospective nature prevents definitive conclusions.
We provide evidence that ESD gives a higher cure rate and is safer than conventional endoscopic resection when applied to early SCCE. ESD warrants prospective comparative studies with conventional endoscopic resection.
内镜黏膜下剥离术(ESD)最初在日本发展,用于整块切除胃肿瘤。
明确新型 ESD 术式是否可行,以及是否可以获得早期食管鳞状细胞癌(SCCE)微创治疗的效果。
回顾性队列研究。
经验丰富的内镜医师进行的单机构试验。
本研究共纳入 300 例连续入组的 SCCE 患者(肿瘤-淋巴结-转移分期 T1、N0),这些患者于 1994 年 3 月至 2007 年 7 月期间分别接受内镜黏膜切除术(EMR,n = 184)或 ESD(n = 116)治疗。
患者接受内镜切除,然后定期接受内镜检查,随访时间 8 至 174 个月(平均 65 个月)。
两组患者的切除率、治愈率、并发症、无病生存率,以及局部复发的危险因素。
ESD 组整块切除率和局部复发率明显优于 EMR 组(P =.0009 和.065)。两组穿孔发生率无显著差异(P =.68)。Cox 回归模型确定了 4 个局部复发的独立危险因素:EMR、癌症浸润较深、食管上段位置和食管癌家族史。在先前内镜切除后,通过对局部复发进行成功的内镜治疗,大多可获得根治。ESD 组的无病生存率明显更好。
本研究为回顾性,无法得出明确结论。
我们的研究结果表明,与传统内镜切除相比,ESD 治疗早期 SCCE 的治愈率更高,且更安全。ESD 值得与传统内镜切除进行前瞻性比较研究。